Suchergebnisse - "Dousset, Christelle"

PubPharm (30)

1

A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics

enthalten in: Blood | 2024

von Durand, R. | Descamps, G. | Bellanger, C. | +17

CommentIn: Blood. 2024 Mar 28;143(13):1202-1204. - PMID 38546638

2

Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma

enthalten in: Haematologica | 2024

von Durand, R. | Bellanger, C. | Kervoëlen, C. | +8

3

CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma

enthalten in: Blood | 2023

von Decombis, S. | Bellanger, C. | Le Bris, Y. | +17

CommentIn: Blood. 2023 Nov 2;142(18):1504-1506. - PMID 37917082

4

The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition

enthalten in: Haematologica | 2022

von Decombis, S. | Papin, A. | Bellanger, C. | +12

CommentIn: Haematologica. 2022 Dec 01;107(12):2774-2775. - PMID 35263987

5

Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells

enthalten in: Frontiers in oncology | 2019

von Tessoulin, B. | Descamps, G. | Dousset, C. | +2

6

The selectivity of Marinopyrrole A to induce apoptosis in MCL1high BCL2low expressing myeloma cells is related to its ability to impair protein translation

enthalten in: British journal of haematology | 2018

von Gomez-Bougie, P. | Dousset, C. | Descamps, G. | +7

7

BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma

enthalten in: British journal of haematology | 2017

von Dousset, C. | Maïga, S. | Gomez-Bougie, P. | +8

8

Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)

enthalten in: Haematologica | 2017

von Touzeau, C. | Le Gouill, S. | Mahé, B. | +7

9

BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma

enthalten in: British journal of haematology | 2017

von Dousset, C. | Maïga, S. | Gomez‐Bougie, P. | +8

10

Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma

enthalten in: Blood | 2016

von Chiron, D. | Bellanger, C. | Papin, A. | +12

CommentIn: Blood. 2016 Dec 15;128(24):2752-2753. - PMID 27979866